🔎 Trials Near Me

Nyumbani › Limfoma ya Selu Kubwa za B Diffuse › Massachusetts › Boston

Majaribio ya kliniki ya Limfoma ya Selu Kubwa za B Diffuse katika Boston, MA

Masomo 16 ya Limfoma ya Selu Kubwa za B Diffuse yanatafuta washiriki katika vituo vya Boston na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

InaajiriHatua 2
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06500273

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

InaajiriHatua 1/2
  • Dana Farber Cancer Institute, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT05006716

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

InaajiriHatua 2
  • Beth Israel Deaconess Medical Center ( Site 0161), Boston
  • Dana Farber Cancer Institute ( Site 0111), Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06890884

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

InaajiriHatua 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

InaajiriHatua 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

InaajiriHatua 1/2
  • Dana-Farber Cancer Institute ( Site 1013), Boston
6 Months – 25 Years · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT06395103

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

InaajiriHatua 2
  • Boston Medical Center, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06806033

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

InaajiriHatua 1/2
  • Massachusetts General Hospital, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT04104776

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

InaajiriUtafiti wa uchunguzi
  • Dana Farber Cancer Institute, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Ago 2026 · NCT06116110

The CARDIOPROTECT Trial

InaajiriHatua 2
  • Beth Israel Deaconess Medical Center, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 27 Jul 2026 · NCT07654426

DALY II USA/ MB-CART2019.1 for DLBCL

InaajiriHatua 2
  • Dana Farber Cancer Institute, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT04792489

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

InaajiriHatua 1
  • Dana Farber Cancer Institute, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Apr 2026 · NCT06451497

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

InaajiriHatua 1
  • Massachusetts General Hospital, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Mac 2026 · NCT06026319

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

InaajiriHatua 2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana Farber Cancer Institute, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Mac 2026 · NCT05800366

Emapalumab Prevention of CAR-T Cell Associated Toxicities

InaajiriHatua 2
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Nov 2025 · NCT06550141

Majaribio ya Limfoma ya Selu Kubwa za B Diffuse katika miji mingine

Masomo mengine katika Boston

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.